Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Boucher

Showing results (541-550 of 682) with videos related to

Pageof 69
Sort By:
Plos One|February 6, 2013
Measuring airway surface liquid depth in ex vivo mouse airways by x-ray imaging for the assessment of cystic fibrosis airway therapiesKaye S Morgan, Martin Donnelley, David M Paganin, et al.
AIDS (London, England)|April 16, 1998
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirD J Kempf, R A Rode, Y Xu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2017
Sialic acid-to-urea ratio as a measure of airway surface hydrationCharles R Esther, David B Hill, Brian Button, et al.
American Journal of Respiratory Cell and Molecular Biology|November 15, 2005
SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosisBarbara R Grubb, Sherif E Gabriel, April Mengos, et al.
American Journal of Respiratory Cell and Molecular Biology|March 31, 2021
Reuse of Cell Culture Inserts for <i>In Vitro</i> Human Primary Airway Epithelial Cell StudiesTakafumi Kato, Yu Mikami, Ling Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapyC E Parr, D M Sullivan, A M Paradiso, et al.
Infection and Immunity|August 27, 2014
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucusUte Schwab, Lubna H Abdullah, Olivia S Perlmutt, et al.
Investigative Ophthalmology & Visual Science|April 30, 2016
Characterization of Rat Meibomian Gland Ion and Fluid TransportDongfang Yu, Richard M Davis, Megumi Aita, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapyC E Parr, D M Sullivan, A M Paradiso, et al.
Plos Pathogens|January 19, 2018
Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool childrenMarianne S Muhlebach, Bryan T Zorn, Charles R Esther, et al.
Pageof 69

Showing results (541-550 of 682) with videos related to

Sort By:
Pageof 69
Plos One|February 6, 2013
Measuring airway surface liquid depth in ex vivo mouse airways by x-ray imaging for the assessment of cystic fibrosis airway therapiesKaye S Morgan, Martin Donnelley, David M Paganin, et al.
AIDS (London, England)|April 16, 1998
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirD J Kempf, R A Rode, Y Xu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2017
Sialic acid-to-urea ratio as a measure of airway surface hydrationCharles R Esther, David B Hill, Brian Button, et al.
American Journal of Respiratory Cell and Molecular Biology|November 15, 2005
SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosisBarbara R Grubb, Sherif E Gabriel, April Mengos, et al.
American Journal of Respiratory Cell and Molecular Biology|March 31, 2021
Reuse of Cell Culture Inserts for <i>In Vitro</i> Human Primary Airway Epithelial Cell StudiesTakafumi Kato, Yu Mikami, Ling Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapyC E Parr, D M Sullivan, A M Paradiso, et al.
Infection and Immunity|August 27, 2014
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucusUte Schwab, Lubna H Abdullah, Olivia S Perlmutt, et al.
Investigative Ophthalmology & Visual Science|April 30, 2016
Characterization of Rat Meibomian Gland Ion and Fluid TransportDongfang Yu, Richard M Davis, Megumi Aita, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapyC E Parr, D M Sullivan, A M Paradiso, et al.
Plos Pathogens|January 19, 2018
Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool childrenMarianne S Muhlebach, Bryan T Zorn, Charles R Esther, et al.
Pageof 69